Attendees will be participating virtually, with live polling, to ensure a broad range of experiences are shared with FDA, biopharmaceutical companies and key stakeholders.
Barry Byrne, MD, PhD, will serve as Chief Medical Advisor; John W. Day, MD, PhD and Matthew B. Harms, MD, to serve as Medical Consultants. Dr. Byrne to lead a Facebook Live Conversation on Thursday, April 2 about how people living with muscular dystrophy,